Print

Purpose

A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Individuals with a positive COVID-19 test between March 15 2020 to November 30 2021 at Northwestern Medicine hospitals.

Exclusion Criteria

Study Design

Phase
Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Arm Groups

ArmDescriptionAssigned Intervention
COVID+ COVID + positive individuals from March 15 2020 to Nov 30, 2021
  • Other: No intervention
    Observational study

Recruiting Locations

More Details

NCT ID
NCT05244096
Status
Active, not recruiting
Sponsor
Northwestern University

Detailed Description

The goal of this study would be to study the association between use of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression and severity.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.